Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Chaoyue Stem Cell Technology is a Chinese biotechnology company specializing in the research, development, and clinical application of stem cell therapies. Based in the Xi'an High-tech Industries Development Zone, the company focuses on mesenchymal stem cells (MSCs) derived from umbilical cord and adipose tissues. Their business model encompasses stem cell banking services, regenerative medicine R&D, and the development of cell-based therapeutics for degenerative and inflammatory diseases. Xi'an Chaoyue operates state-of-the-art GMP-compliant laboratories and has established collaborations with leading clinical institutions for translational research. The company's pipeline includes programs for knee osteoarthritis and liver cirrhosis, aiming to provide innovative solutions in the field of precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an ChaoYue Stem Cell.